09.10.2023 -
Bristol-Myers Squibb (BMS) announced that it will acquire Mirati Therapeutics for up to $5.8 billion. BMS is to pay $58.00 per share in cash, for a total equity value of...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)